BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 17725861)

  • 1. Gu Ling Pian, a traditional Chinese medicine, regulates function and OPG/RANKL synthesis of osteoblasts via the p38 MAPK pathway.
    Zhao Y; Li J; Liu Y; Yu KQ; Zhang J; Chen XG
    J Pharm Pharmacol; 2007 Aug; 59(8):1167-73. PubMed ID: 17725861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guling tablets promotes the proliferation and mineralization and regulates OPG/RANKL/M-CSF expression of osteoblasts via the p38 MAPK pathway in vitro].
    Huang SH; Zhang J; Li J; Cai HB
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1148-50. PubMed ID: 18676248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts.
    Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells].
    Wang BL; Zheng F; Qiu MC
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats.
    Mai QG; Zhang ZM; Xu S; Lu M; Zhou RP; Zhao L; Jia CH; Wen ZH; Jin DD; Bai XC
    J Cell Biochem; 2011 Oct; 112(10):2902-9. PubMed ID: 21618594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro induction studies of YouGui drink on culture of steroid induced necrosis of femoral head rat osteoblast].
    Tong PJ; Xu L; Hu BS; Jin HT; Li TY; Fang X
    Zhongguo Gu Shang; 2010 Jan; 23(1):23-7. PubMed ID: 20191959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of calcitonin on osteoblast cell proliferation and OPG/RANKL expression: experiment with mouse osteoblasts].
    Tian QX; Huang GY; Zhou JL; Liu QH; DU XR
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1501-5. PubMed ID: 17785093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol protects against ethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kappaB ligand in osteoblasts.
    Chen JR; Haley RL; Hidestrand M; Shankar K; Liu X; Lumpkin CK; Simpson PM; Badger TM; Ronis MJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1182-90. PubMed ID: 16971503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts.
    Zhang H; Xing WW; Li YS; Zhu Z; Wu JZ; Zhang QY; Zhang W; Qin LP
    Maturitas; 2008 Dec; 61(4):334-9. PubMed ID: 19004583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
    Brechter AB; Lerner UH
    Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
    Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
    J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells.
    Pantouli E; Boehm MM; Koka S
    Biochem Biophys Res Commun; 2005 Apr; 329(1):224-9. PubMed ID: 15721297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand in human osteoblast].
    Zhang XM; Xie H; Yuan LQ; Luo XH; Liao EY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1562-5. PubMed ID: 18956641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
    Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin decreases expression of Runx2, osteoprotegerin, and RANKL in primary osteoblasts derived from tibiae of adult female rats.
    Charoenphandhu N; Teerapornpuntakit J; Methawasin M; Wongdee K; Thongchote K; Krishnamra N
    Can J Physiol Pharmacol; 2008 May; 86(5):240-8. PubMed ID: 18432284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio.
    Rauner M; Stupphann D; Haas M; Fert I; Glatigny S; Sipos W; Breban M; Pietschmann P
    J Rheumatol; 2009 Jan; 36(1):120-6. PubMed ID: 19040304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.